What makes cancer stem cell markers different?

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-8

  Karsten, Uwe ^a   Goletz, Steffen ^a  

^a GLYCOTOPE GMBH   (Germany)

Author keywords

Cancer stem cells; Glycosylation; Stem cells; Therapeutic targets; Thomsen Friedenreich antigen

Indexed keywords

EID: 84881247532     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-301     Document Type: Article

References (114)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988
2. Annaloro C, Onida F, Saporiti G, Lambertenghi Deliliers G (2011) Cancer stem cells in hematological disorders: current and possible new therapeutic approaches. Curr Pharm Biotechnol 12:217-225
3. Augello A, Kurth TB, De Bari C (2010) Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cells Mat 20:121-133
4. Baba M, Ma BY, Nonaka M, Matsuishi Y, Hirano M, Nakamura N, Kawasaki N, Kawasaki N, Kawasaki T (2007) Glycosylation-dependent interaction of Jacalin with CD45 induces T lymphocyte activation and Th1/Th2 cytokine secretion. J Leukoc Biol 81:1002-1011
5. Badcock G, Pigott C, Goepel J, Andrews PW (1999) The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratin sulfate proteoglycan. Cancer Res 59:4715-4719
6. Baldus SE, Zirbes TK, Hanisch FG, Kunze D, Shafizadeh ST, Nolden S, Mönig SP, Schneider PM, Karsten U, Thiele J, Hölscher AH, Dienes HP (2000) Thomsen-Friedenreich (TF) antigen presents as a prognostic factor in colorectal carcinoma: a clinico-pathological study including 264 patients. Cancer 88:1536-1543
7. Barrow H, Tam B, Duckworth CA, Rhodes JM, Yu L-G (2013) Suppression of core-1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and core-3 glycans in human colon cancer cells. PLoS One 8:e59792. doi:10.1371/journal.pone.0059792
8. Basso G, Timeus F (1998) Cytofluorimetric analysis of CD34 cells. Bone Marrow Transplant Suppl 5:S17-S20
9. Battula VL, Shi Y, Evans KW, Wang R-Y, Spaeth EL, Jacamo RO, Guerra R, Sahin AA, Marini FC, Hortobagyi G, Mani SA, Andreeff M (2012) Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. J Clin Invest 122:2066-2078
10. Beuth J, Ko HL, Schirrmacher V, Uhlenbruck G, Pulverer G (1988) Inhibition of liver tumor cell colonization in two animal tumor models by lectin blocking with D-galactose or arabinogalactan. Clin Exp Metastasis 6:115-120
11. Blanpain C, Fuchs E (2006) Epidermal stem cells of the skin. Annu Rev Cell Dev 22:339-373
12. Brockhausen I (1999) Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1473:67-95
13. Bunting KD (2002) ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 20:11-20
14. Cao Y, Karsten U, Liebrich W, Haensch W, Springer GF, Schlag PM (1995) Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas: a reevaluation. Cancer 76:1700-1708
15. Cao Y, Stosiek P, Springer GF, Karsten U (1996) Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem Cell Biol 106:197-207
16. Cao Y, Blohm D, Ghadimi BM, Stosiek P, Xing P-X, Karsten U (1997) Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation. J Histochem Cytochem 45:1547-1557
17. Cao Y, Karsten U, Otto G, Bannasch P (1999) Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and α2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Virchows Arch 434:503-509
18. Cao Y, Karsten U, Zerban H, Bannasch P (2000) Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions. Virchows Arch 436:119-126
19. + hematopoietic progenitors but absent on mature lymphocytes. Glycobiology 11:677-683
20. Cao Y, Merling A, Karsten U, Goletz S, Punzel M, Kraft R, Butschak G, Schwartz-Albiez R (2008) Expression of CD175 (Tn), CD175s (sialosyl-Tn) and CD176 (Thomsen-Friedenreich antigen) on malignant human hematopoietic cells. Int J Cancer 123:89-99
21. Carpenter MK, Rosler E, Rao MS (2003) Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 5:79-88
22. Chang W-W, Lee CH, Lee P, Lin J, Hsu C-W, Hung J-T, Lin J-J, Yu J-C, Shao L, Yu J, Wong C-H, Yu AL (2008) Expression of globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in globo H synthesis. Proc Natl Acad Sci USA 105:11667-11672
23. Clausen H, Stroud M, Parker J, Springer G, Hakomori S-I (1988) Monoclonal antibodies directed to the blood group A associated structure, glactosyl-A: specificity and relation to the Thomsen-Friedenreich antigen. Mol Immunol 25:199-204
24. Cloosen S, Gratama JW, van Leeuwen EBM, Senden-Gijsbers BLMG, Oving EBH, von Mensdorff-Pouilly S, Tarp MA, Mandel U, Clausen H, Germeraad WTV, Bos GMJ (2006) Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma. Brit J Haematol 135:513-516
25. Dabelsteen E (1996) Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 179:358-369
26. Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58:267-284
27. Dell'Albani P (2008) Stem cell markers in gliomas. Neurochem Res 33:2407-2415
28. Ding Y, Gelfenbeyn K, Freire-de-Lima L, Handa K, Hakomori S-I (2012) Induction of epithelial-esenchymal transition with O-glycosylated oncofetal fibronectin. FEBS Lett 585:1813-1820
29. Engelmann K, Shen H, Finn OJ (2008) MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res 68:2419-2426
30. Fatrai S, Schepers H, Tadema H, Vellenga E, Daenen SMGJ, Schuringa JJ (2008) Mucin 1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases. Exp Hematol 36:1254-1265
31. Fenderson BA, Andrews PW (1992) Carbohydrate antigens of embryonal carcinoma cells: changes upon differentiation. APMIS 100(Suppl 27):109-118
32. Furness SGB, McNagny K (2006) Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis. Immunol Res 34:13-32
33. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RCR (2007) SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109:1743-1751
34. 3 integrin. J Biol Chem 274:13060-13065
35. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer C, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555-567
36. Goletz S, Cao Y, Danielczyk A, Ravn P, Schöber U, Karsten U (2003) Thomsen-Friedenreich antigen: the "hidden"tumour antigen. Adv Exp Med Biol 535:147-162
37. Guha P, Kaptan E, Bandyopadhyaya G, Kaczanowska S, Davila E, Thompson K, Martin SS, Kalvakolanu DV, Vasta GR, Ahmed H (2013) Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis. Proc Natl Acad Sci USA 110:5052-5057
38. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24
39. Guo W, Lasky JL, Chang C-J, Mosessian S, Lewis X, Xiao Y, Yeh JE, Chen JY, Iruela-Arispe ML, Varella-Garcia M, Wu H (2008) Multi-genetic events collaboratively contribute to Pten-null leukemia stem-cell formation. Nature 453:529-533
40. Gupta V, Bhinge KN, Hosain SB, Xiong K, Gu X, Shi R, Ho M-Y, Khoo K-H, Li S-C, Li Y-T, Ambudkar SV, Jazwinski SM, Liu Y-Y (2012) Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells. J Biol Chem 287:37195-37205
41. Hakomori S-I (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52:257-331
42. Hakomori S (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56:5309-5318
43. Havens AM, Jung Y, Sun YX, Wang J, Shah RB, Bühring HJ, Pienta KJ, Taichman RS (2006) The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer 6:195
44. Hemmoranta H, Satomaa T, Blomqvist M, Heiskanen A, Aitio O, Saarinen J, Natunen J, Partanen J, Laine J, Jaatinen T (2007) N-glycan structures and associated gene expression reflect the characteristic N-glycosylation pattern of human hematopoietic stem and progenitor cells. Exp Hematol 35:1279-1292
45. Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, Moore H, Andrews PW (2002) Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20:329-337
46. Hennen E, Faissner A (2012) Lewis X: a neural stem cell specific glycan? Int J Biochem Cell Biol 44:830-833
47. Hernandez JD, Klein J, Van Dyken SJ, Marth JD, Baum LG (2007) T-cell activation results in microheterogeneous changes in glycosylation of CD45. Int Immunol 19:847-856
48. Huang Y-C, Yang Z-M, Chen X-H, Tan M-Y, Wang J, Li X-Q, Xie H-Q, Deng L (2009) Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev 5:247-255
49. Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS (1989) Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 49:197-204
50. Jeschke U, Richter DU, Hammer A, Briese V, Friese K, Karsten U (2002) Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro. Histochem Cell Biol 117:219-226
51. Kang M-K, Kang S-K (2007) Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Developm 16:837-847
52. Kannagi R, Cochran NA, Ishigami F, Hakomori S-I, Andrews PW, Knowles BB, Solter D (1983) Stage-specific embryonic antigens (SSEA-3 and-4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2:2355-2361
53. Karsten U, Butschak G, Cao Y, Goletz S, Hanisch F-G (1995) A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen. Hybridoma 14:37-44
54. Karsten U, von Mensdorff-Pouilly S, Goletz S (2005) What makes MUC1 a tumor antigen? Tumor Biol 26:217-220
55. Kemper K, Sprick MR, de Bree M, Scopelliti A, Vermeulen L, Hoeke M, Zeilstra J, Pals ST, Mehmet H, Stassi G, Medema JP (2010) The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 70:719-729
56. Krause DS, Fackler MJ, Civin CI, May WS (1996) CD34: structure, biology, and clinical utility. Blood 87:1-13
57. Krupkova O, Loja T, Zambo I, Veselska R (2010) Nestin expression in human tumors and tumor cell lines. Neoplasma 57:291-298
58. La Barge MA, Petersen OW, Bissell MJ (2007) Of microenvironments and mammary stem cells. Stem Cell Rev 3:137-146
59. Langkilde NC, Wolf H, Clausen H, Orntoft TF (1992) Human urinary bladder carcinoma glycoconjugates expressing T-(Galβ(1-3)GalNAcα1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly-and monoclonal antibodies. Cancer Res 52:5030-5036
60. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Clement M (2001) ABH and Lewis histo-blood group antigens in cancer. APMIS 109:9-31
61. Limas C, Lange P (1986) T-antigen in normal and neoplastic urothelium. Cancer 58:1236-1245
62. Lin W-M, Karsten U, Goletz S, Cheng R-C, Cao Y (2010a) Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells. Int J Exp Pathol 92:97-105
63. Lin W-M, Karsten U, Goletz S, Cheng R-C, Cao Y (2010b) Expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells. Virchows Arch 456:403-409
64. + cancer stem cells in glioblastoma. Mol Cancer 5:67. doi:10.1186/1476-4598-5-67
65. Lloyd KO, Burchell J, Kudryashov V, Yin BWT, Taylor-Papadimitriou J (1996) Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. J Biol Chem 271:33325-33334
66. Lobo NA, Shimono Y, Qian D, Clarke MF (2007) The biology of cancer stem cells. Annu Rev Cell Dev Biol 23:675-699
67. Lukacs RU, Memarzadeh S, Wu H, Witte ON (2010) Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 7:682-693
68. Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PWK (2011) Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 29:32-45
69. Masuzawa Y, Miyauchi T, Hamanoue M, Ando S, Yoshida J, Takao S, Shimazu H, Adachi M, Muramatsu T (1992) A novel core protein as well as polymorphic epithelial mucin carry peanut agglutinin binding sites in human gastric carcinoma cells: sequence analysis and examination of gene expression. J Biochem 112:609-615
70. Matsuura H, Takio K, Titani K, Greene T, Levery SB, Salina MEK, Hakomori S (1988) The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6: unique structural requirement for the antigenic specificity provided be a glycosylhexapeptide. J Biol Chem 263:3314-3322
71. Medema JP (2013) Cancer stem cells: the challenges ahead. Nature Cell Biol 15:338-344
72. Miyauchi T, Kanekura T, Yamaoka A, Ozawa M, Miyazawa S, Muramatsu T (1990) Basigin, a new, broadly distributed member of the immunoglobulin superfamily, has strong homology with both the immunoglobulin V domain and the β-chain of major histocompatibility complex class II antigen. J Biochem 107:316-323
73. Mizrak D, Brittan M, Alison MR (2008) CD133: molecule of the moment. J Pathol 214:3-9
74. Monk M, Holding C (2001) Human embryonic genes re-expressed in cancer cells. Oncogene 20:8085-8091
75. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C, Gritti A, Piccini A, Porro D, Santinami M, Invernici G, Parati E, Alessandri G, LaPorta CAM (2007) Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 43:935-946
76. Muramatsu T (1988) Alterations of cell-surface carbohydrates during differentiation and development. Biochimie 70:1587-1596
77. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110
78. Okuno K, Shirayama Y, Ohnishi H, Yamamoto K, Ozaki M, Hirohata T, Nakajima I, Yasutomi M (1993) A successful liver metastasis model in mice with neuraminidase treated colon 26. Surg Today 23:795-799
79. Ponnusamy MP, Batra SK (2008) Ovarian cancer: emerging concept on cancer stem cells. J Ovarian Res 1. doi:10.1186/1757-2215-1-4
80. Pontier SM, Muller WJ (2009) Integrins in mammary-stem-cell biology and breast-cancer progression-a role in cancer stem cells? J Cell Sci 122:207-214
81. Poppema S, Lai R, Visser L, Yan XJ (1996) CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets. Leuk Lymphoma 20:217-222
82. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-111
83. Ricci-Vitani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115
84. Riethdorf S, Reimers N, Assmann V, Kornfeld J-W, Terracciano L, Sauter G, Pantel K (2006) High incidence of EMMPRIN expression in human tumors. Int J Cancer 119:1800-1810
85. Salcido CD, Larochelle A, Taylor BJ, Dunbar CE, Varticovski L (2010) Molecular characterization of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Brit J Cancer 102:1636-1644
86. Sangiorgi E, Capecchi MR (2008) Bmi1 is expressed in vivo in intestinal stem cells. Nature Genet 40:915-920
87. Schäfer R, Schnaidt M, Klaffschenkel RA, Siegel G, Schüle M, Rädlein MA, Hermanutz-Klein U, Ayturan M, Buadze M, Gassner C, Danielyan L, Kluba T, Northoff H, Flegel WA (2011) Expression of blood group genes by mesenchymal stem cells. Brit J Haematol 153:520-528
88. Schindlbeck C, Jeschke U, Schulze S, Karsten U, Janni W, Rack B, Sommer H, Friese K (2005) Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen. Histochem Cell Biol 123:631-637
89. Schlepper-Schäfer J, Springer GF (1989) Carcinoma autoantigens T and Tn and their cleavage products interact with Gal/GalNAc-specific receptors on rat Kupffer cells and hepatocytes. Biochim Biophys Acta 1013:266-272
90. Shigeoka H, Karsten U, Okuno K, Yasutomi M (1999) Inhibition of liver metastases from neuraminidase-treated Colon 26 cells by an anti-Thomsen-Friedenreichspecific monoclonal antibody. Tumor Biol 20:139-146
91. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Dien M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, Pera RAR, Lao K, Clarke MF (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138:592-603
92. Singh R, Campbell BJ, Yu L-G, Fernig DG, Milton JD, Goodlad RA, FitzGerald AJ, Rhodes JM (2001) Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44. Glycobiology 11:587-592
93. Slawson C, Hart GW (2011) O-GlcNAc signaling: implications for cancer cell biology. Nat Rev Cancer 11:678-684
94. Solter D, Knowles BB (1978) Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 75:5565-5569
95. Son MJ, Woolard K, Nam D-H, Lee J, Fine HA (2009) SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4:440-452
96. Springer GF (1984) T and Tn, general carcinoma autoantigens. Science 224:1198-1206
97. Springer GF (1997) Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J Mol Med 75:594-602
98. Springer GF, Desai PR, Banatwala I (1975) Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. J Natl Cancer Inst 54:335-339
99. Springer GF, Desai PR, Tegtmeyer H, Carlstedt SC, Scanlon EF (1994) T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced human breast carcinoma. Cancer Biotherapy 9:7-15
100. Srour EF, Brandt JE, Briddell RA, Leemhuis T, van Besien K, Hoffman R (1991) Human CD34+ HLA-DR-bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. Blood Cells 17:287-295
101. Taddei I, Deugnier M-A, Faraldo MM, Petit V, Bouvard D, Medina D, Fässler R, Thiery JP, Glikhova MA (2008) β1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nature Cell Biol 10:716-722
102. Takaishi S, Okumura T, Tu S, Wang SSW, Shibata W, Vigneshwaran R, Gordon SAK, Shimada Y, Wang TC (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27:1006-1020
103. Tang C, Lee AS, Volkmer J-P, Sahoo D, Nag D, Mosley AR, Inlay MA, Ardehali R, Chavez SL, Pera RR, Behr B, Wu JC, Weissman IL, Drukker M (2011) An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nature Biotechnol 29:829-834
104. Tardio JC (2009) CD34-reactive tumors of the skin. An updated review of an evergrowing list of lesions. J Cutan Pathol 36:1079-1092
105. + cells. Leuk Lymphoma 37:1-25
106. Wearne KA, Winter HC, Goldstein IJ (2008) Temporal changes in the carbohydrates expressed on BG01 human embryonic stem cells during differentiation as embryoid bodies. Glycoconj J 25:121-136
107. Wenk J, Andrews PW, Casper J, Hata J-I, Pera MF, von Keitz A, Damjanov I, Fenderson BA (1994) Glycolipids of germ cell tumors: extended globo-series glycolipids are a hallmark of human embryonal carcinoma cells. Int J Cancer 58:108-115
108. Yanagisawa M, Yoshimura S, Yu RK (2011) Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells. ASN NEURO 3. doi:10.1042/AN20110006, art:e00054
109. Yi B, Zhang M, Schwartz-Albiez R, Cao Y (2011) Mechanisms of the apoptosis induced by CD176 antibody in human leukemic cells. Int J Oncol 38:1565-1573
110. Yu L-G, Andrews N, Zhao Q, McKean D, Williams JF, Connor LJ, Gerasimenko OV, Hilkens J, Hirabayashi J, Kasai K, Rhodes JM (2007) Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem 282:773-781
111. Zebda N, Bailly M, Brown S, Doré JF, Berthier-Vergnes O (1994) Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential. J Cell Biochem 54:161-173
112. Zhang S, Zhang HS, Cordon-Cardo C, Reuter VE, Singhal AK, Lloyd KO, Livingston PO (1997) Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens. Int J Cancer 73:50-56
113. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP (2008) Identification and characterization of ovarian cancerinitiating cells from primary human tumors. Cancer Res 68:4311-4320
114. Zöller M (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11:254-267